WeVote

Bill

Bill

HB 386

Back to School Relief Act; enact

2025-2026 Regular Session Introduced by Kimberly Alexander and 5 co-sponsors

HB 386 enhances penalties for fentanyl-related offenses, empowers prosecutors, and promotes public health initiatives to combat the opioid crisis and improve community safety.

House Second Readers
0
WeVote Research Nonpartisan
Bill Summary · HB 386

Summary of HB 386: Relating to Dangerous Drugs

Bill Overview

Bill Number: HB 386
Title: Relating to Dangerous Drugs
Status: Act 004, effective April 10, 2025
Introduced: January 16, 2025
Classification: Bill
Subject Areas: Criminal Offenses, Fentanyl, Honolulu Prosecuting Attorney Package, Offenses Relating to Drugs and Intoxicating Compounds

Purpose and Intent

The primary purpose of HB 386 is to address the growing concerns surrounding dangerous drugs, particularly focusing on the opioid crisis and the prevalence of fentanyl. The bill aims to enhance the legal framework for prosecuting offenses related to dangerous drugs, thereby improving public safety and health outcomes.

Key Provisions

  • Enhanced Penalties: The bill introduces stricter penalties for offenses involving fentanyl and other dangerous drugs, aiming to deter drug trafficking and distribution.
  • Prosecutorial Authority: It grants additional authority to the Honolulu Prosecuting Attorney to pursue cases related to dangerous drugs more effectively.
  • Public Health Measures: The legislation may include provisions for public health initiatives aimed at education and prevention regarding the dangers of fentanyl and other drugs.

Impact

  • Law Enforcement and Prosecutors: The bill will provide law enforcement agencies and prosecutors with more robust tools to combat drug-related offenses, particularly those involving fentanyl.
  • Public Health: By addressing the opioid crisis, the bill seeks to reduce the incidence of drug overdoses and related health issues in the community.
  • Community Awareness: The bill may lead to increased public awareness and education regarding the dangers of fentanyl and other dangerous drugs.

Legislative Process and Timeline

  • Introduced: January 16, 2025
  • Passed First Reading: March 4, 2025
  • Passed Second Reading: February 27, 2025
  • Passed Third Reading in House: February 28, 2025
  • Transmitted to Senate: February 28, 2025
  • Passed Third Reading in Senate: March 27, 2025
  • Transmitted to Governor: March 27, 2025
  • Signed into Law: April 10, 2025

Sponsors

  • Primary Sponsor: Representative Nakamura

Related Legislation

  • Companion Bill: SB 279

This summary provides a comprehensive overview of HB 386, highlighting its intent, key provisions, and potential impacts on public health and safety. The bill represents a significant step in addressing the challenges posed by dangerous drugs in the community.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.